US Stock MarketDetailed Quotes

KALV KalVista Pharmaceuticals

Watchlist

12.340
+2.340+23.40%

Close Sep 27 16:00 ET

12.340
0.0000.00%

Post 19:12 ET

533.28MMarket Cap-3456P/E (TTM)

KalVista Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KalVista Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q3	-- / 1.973M	--
--	2025/Q2	-- / 0.000	--
--	2025/Q1	0.000 / 0.000	--
--	2024/Q4	0.000 / 0.000	--
--	2024/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q3-- / 1.973M--

--2025/Q2-- / 0.000--

--2025/Q10.000 / 0.000--

--2024/Q40.000 / 0.000--

--2024/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

KalVista Pharmaceuticals Earnings Reports

KalVista Pharmaceuticals | 10-Q: Q1 2025 Earnings Report

Sep 5 16:18 ET

KalVista Pharmaceuticals | 10-K: FY2024 Annual Report

Jul 11 16:15 ET

KalVista Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Mar 11 16:28 ET

KalVista Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Dec 7, 2023 16:07 ET

Analyst Rating

Updated: Sep 27, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall